Envoy Medical

04/15/2026

Ever feel worn out after listening all day?

When you have hearing loss, your brain works extra hard to fill in the gaps—especially in meetings, group conversations, restaurants, or noisy places.

Over time, that constant effort can lead to fatigue, headaches, and stress.

Remember to take breaks, reduce background noise when possible, and use captions and other visual cues to help support communication!

04/06/2026

Envoy Medical has reached an important milestone.

The first three patients in our Acclaim® cochlear implant pivotal clinical study have reached their 12-month follow-up.

"We believe our first-of-its-kind breakthrough technology has the potential to change the perception around how severe to profound hearing loss is treated", says Envoy CEO Brent Lucas

Learn more here: https://hubs.li/Q049K3vB0

Caution: Investigational device. Limited by federal (or United States) law to investigational use.

03/25/2026

According to the Hearing Loss Association of America, people wait an average of about seven years from when they first suspect hearing loss to when they seek treatment.

If you’re living with hearing loss, how long did you wait to take action—and what do you wish you had done sooner?

03/18/2026

Did you know your diet may affect your hearing?

Recent studies show people who eat more fish, colorful fruits/vegetables, and antioxidant‑rich foods have a lower risk of hearing loss.

Learn more here: https://hubs.li/Q047msQX0

Healthy eating = Healthy hearing.
Happy National Nutrition Month!

03/11/2026

A Big Step Forward for People Living With Severe to Profound Hearing Loss!

Envoy Medical has reached an exciting milestone: the U.S. clinical trial studying the fully implanted Acclaim® Cochlear Implant has now finished enrolling participants, and the research team is moving into the follow‑up phase.

This investigational device is being studied as a potential option for adults who want a fully implanted approach—without external components worn on or in the ear. The final participants in the trial were implanted this week, and the study will now move into the follow‑up phase.

Hearing loss can be isolating, emotional, and frustrating. Many people have shared that they’ve been waiting for a fully implanted cochlear implant to even consider surgery. Hearing those stories is a big part of why this research matters.

While the Acclaim cochlear implant is not yet FDA‑approved and is still being studied, completing this phase of the trial brings us one step closer to understanding whether this fully implanted technology may become an option in the future.

Read the full press release here: https://hubs.li/Q046n4Vg0

CAUTION: The fully implanted Acclaim Cochlear Implant is an investigational device, limited by federal law to investigational use.

03/03/2026

Celebrating World Hearing Day!

Today we’re highlighting the importance of routine hearing screening in schools. Early checks help identify issues before they affect a child’s communication, learning, and long‑term outcomes.

While Envoy Medical’s implantable technologies are designed for adults, we proudly support efforts that strengthen early detection and timely referral for children through school health programs.

Early screening changes lives. 💙

02/25/2026

🌎Celebrating International Cochlear Implant Day!

Cochlear implants are an important option for people with more significant hearing loss who may not receive enough benefit from traditional hearing aids. Unlike hearing aids, which amplify sound acoustically, cochlear implants work by bypassing the damaged areas of the inner ear and delivering sound information through electrical stimulation of the auditory nerve.

Today, we join the global community in raising awareness of cochlear implant technology, ongoing research, and the many individuals and organizations who advance the field.

As our own fully implanted cochlear implant system remains investigational and is currently being studied in U.S FDA clinical trials, we are proud to support awareness efforts and contribute to continued innovation in hearing health.

Please join us in spreading awareness on February 25 by using the hashtag .

CAUTION: Investigational device. Limited by federal (or United States) law to investigational use.

02/25/2026

ICYMI! We hope you can join us this morning!

We invite you to join Envoy Medical for a Fireside Chat on Wednesday, February 25, 2026, at 10:00 a.m. ET.

Brent Lucas, Envoy Medical’s CEO, will host a discussion with Dr. Theodore McRackan, a Principal Investigator in the Acclaim® pivotal clinical trial and a cochlear implant surgeon at the Medical University of South Carolina.

Dr. McRackan has implanted 14 of the 47 subjects enrolled to date—the first site in this pivotal clinical trial to reach this milestone. During the conversation, he will share early impressions, insights, and the potential impact of Envoy Medical’s fully implanted technology pending future regulatory submission and approval.

Event: Envoy Medical Fireside Chat
Date: Wednesday, February 25, 2026
Time: 10:00 a.m. ET
Register: https://hubs.li/Q044Cq180

We look forward to having you join us.
CAUTION: Investigational device. Limited by federal (or United States) law to investigational use.

02/24/2026

We’re excited to share an important update from Envoy Medical!

Nasdaq has formally confirmed that Envoy Medical (NASDAQ: COCH) is back in compliance with its continued listing requirements. Thanks to our recent strategic financing efforts and a stronger balance sheet, we are pleased to continue trading on the Nasdaq Capital Market under the symbol COCH.

This milestone supports the continued momentum of our work to bring forward fully implanted hearing technologies like the Esteem® FI‑AMEI and the investigational Acclaim® Cochlear Implant.

Learn more here: https://hubs.li/Q044rNNp0

CAUTION. The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use.

Envoy Medical regains Nasdaq compliance through strategic financing, ensuring continued innovation in fully implanted hearing solutions. Learn more about their groundbreaking technologies and future plans.

02/23/2026

We’ve secured three new patents — one in the United States and two in Hong Kong — helping us continue our work in the future of fully implanted hearing technology.

At Envoy Medical, we’re developing a different approach to hearing solutions. Our Nature’s Microphone™ technology is designed to use the natural ear to capture sound, rather than relying on external microphones or devices worn on or in the ear. Many people with hearing loss rely on devices that need to be put on, removed, or managed throughout the day — which can mean there are moments when they’re not connected to sound. We’re working on a path that could one day help change that.

This different approach is present in our investigational Acclaim® Cochlear Implant, which is currently being evaluated in a U.S. pivotal clinical trial. Our goal is to advance technology that prioritizes access, ease of use, and long‑term usability and these patents further support that goal.

We’re grateful to everyone who supports Envoy Medical — including the hearing loss community and the families who walk alongside them. Your encouragement keeps us moving forward as we work to push hearing technology beyond the status quo.

Learn more here: https://hubs.li/Q044dT3p0


CAUTION: The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use.

Envoy Medical secures three new patents, reinforcing its competitive edge in fully implanted hearing solutions and paving the way for future innovations in the cochlear implant industry.

02/19/2026

Progress Toward a New Fully Implanted Option for Hearing Loss

Envoy Medical is making important progress in our pivotal clinical trial for the investigational fully implanted Acclaim® Cochlear Implant. Forty‑seven people have already been implanted, and the remaining participants are scheduled for surgery. Once enrollment is complete, each participant will be followed for one year. The next major step is gathering and analyzing that data as we move toward the regulatory submission and review process.

We also recently secured new financing that helps us continue advancing this work.

On February 25 at 10 a.m. ET, Envoy Medical’s CEO will host a Fireside Chat with Dr. Theodore McRackan, a surgeon who has implanted the Acclaim® cochlear implant in 14 trial participants. They will discuss early insights and the potential impact of this technology if it is approved.

Link to press release:https://hubs.li/Q043SHJS0

Register here: https://hubs.li/Q043SJdw0

CAUTION: The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use.

Envoy Medical secures $78M in financing, advancing their investigational and innovative cochlear implant technology towards commercialization with promising clinical trial progress and insights from Dr. Theodore McRackan.

02/17/2026

We’ve been busy at Envoy Medical — and the momentum is strong!

We’re excited to share that 45 of 56 participants have now been implanted with our investigational fully implanted Acclaim® cochlear implant in the pivotal clinical trial, putting it at over 80% enrolled. Full enrollment is anticipated by the end of March.

"Reaching 45 implanted patients and being approximately one month away from full enrollment is an exciting milestone for our entire organization. The journey to get to this point has been long, but we are now moving quickly and with great confidence." — Brent Lucas, CEO

The Acclaim® implant is designed to leverage the ear to capture sound with no external components worn on or in the ear – similar to the way nature intended.

Learn more here:https://hubs.li/Q043nKHn0

CAUTION: The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use.